InYourArea Community
Leicester patients help prove arthritis medicines boost COVID survival
Patients, researchers, and clinicians at Leicester's hospitals contributed important data to the REMAP-CAP trial, which evaluates the effect of treatments on survival rates and the length of time patients need support in an intensive care unit.